Dudnyk’s “Mantra” campaign for Shire’s Firazyr earns PM360 Pharma Choice Award
The campaign Dudnyk created for Shire’s Firazyr, called “Mantra,” took home the Bronze award for DTC/DTP.
Dudnyk Wins Pharma Choice Gold Award from PM360
PM360, a leading trade magazine in the pharmaceutical, biotech, and medical device industries, has awarded Dudnyk the Gold Pharma Choice Award for Professional Print Campaign for Flexion Therapeutics’ Zilretta.
Dudnyk Executives Featured in the MAN Agency Roundtable Issue
Several Dudnyk team members contributed to the latest issue of Med Ad News. Read our thoughts on topics ranging from patient engagement strategies to the Opioid Epidemic to AR/VR in the annual Healthcare Agency Roundtable.
The Innovation of “The Unifying Effect”
Dudnyk's “The Unifying Effect” was named a 2017 Innovative Strategy by PM360. See how we are changing the way physicians and patients in specialty and rare disease communities connect.
Advancements in Molecular Medicine
PharmaVOICE Trends for the Future: Christopher Tobias, PhD, discusses how major ongoing advancements in molecular medicine in clinical trials are delivering results in the form of FDA-approved treatments for diseases that previously meant bleak long–term outcomes for patients.
The Responsibility of Marketing for Rare Diseases
PharmaVOICE Trends for the Future: Laurie Bartolomeo shares insight into the motivations of marketing to patients with rare diseases. The responsibility to patients is heightened in the rare disease space, she explains, and where there is greater need, there is greater reward.
DUDNYK NAMED MM&M HEALTHCARE AGENCY OF THE YEAR AWARD WINNER
Wins Silver Award in small agency category.
Dudnyk Named PM360 Trailblazer Gold Award Winner
Agency recognized five times including Direct-to-Patient Campaign and Professional Campaign.
EVP CD Laurie Bartolomeo stresses the importance of advocacy groups
A rare disease requires an exhausting level of diligence and attention.
Dudnyk Named PM360 Trailblazer Award Finalist in Multiple Categories
Agency recognized five times including Direct-to-Patient Campaign and Professional Campaign
Dudnyk Named a Best Place to Work
The Philadelphia Business Journal and Quantum Workplace have named Dudnyk a Best Place to Work. The agency received the honor at a breakfast banquet at The Filmore this morning, achieving recognition in the category of medium-sized companies with 50-99 employees.
Working with Advocacy Groups
MM&M asked Laurie Bartolomeo how marketers can partner with advocacy groups to achieve brand objectives for rare disease patients.
Dudnyk in the latest PhillyAdNews
Find out exactly what we mean by The Unifying Effect, our new agency branding, in the latest issue of PhillyAdNews.
2017 MM&M Top 100 Agency
Dudnyk is honored to be featured, once again, as a top 100 agency by MM&M.
Client and Agency Do's and Don'ts
Like all good relationships, a successful client and agency partnership relies on transparency, communication, trust and commitment. Annemarie Armstrong, along with Dudnyk client Manny Gaspar of Shire, share with PharmaVOICE just what makes their collaboration so strong.
Expert Q & A on The Patient Journey in the June MM&M
The June issue of MM&M includes an expert Q & A on The Patient Journey, and the struggle to get it right. Laurie Bartolomeo contributes.
The Unifying Effect
Inspiring empathy, understanding, and shared responsibility in HCP-patient interactions
Dudnyk Introduces New Agency Branding, Identifies The Unifying Effect
New positioning, web site, and ad campaign underscore the importance of uniting patients and HCPs
Overcoming Marketing Roadblocks
Laurie Bartolomeo weighs in on the biggest roadblocks pharma marketers face.
A Nuanced Message: Marketing to the Rare Diseases Community
Marketing to rare disease communities requires a different kind of strategy.
© Dudnyk
Trademarks are the property of their respective owners.
Trademarks are the property of their respective owners.